Related Experiment Video
Updated: Feb 5, 2026

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
Published on: September 20, 2020
CellSaic, A Cell Aggregate-Like Technology Using Recombinant Peptide Pieces for MSC Transplantation
1Bioscience & Technology Development Center, FUJIFILM Corporation, Kanagawa/258-8577, Japan.
CellSaic, a novel 3D platform using recombinant peptide scaffolds, prevents cell death in mesenchymal stem cell (MSC) transplants. This innovation enhances therapeutic effects for conditions like inflammatory bowel disease and bone regeneration.
Area of Science:
- Regenerative Medicine
- Biomaterials Engineering
- Stem Cell Therapy
Background:
- Mesenchymal stem cells (MSCs) show therapeutic potential but transplantation methods need optimization.
- Traditional cell suspensions face limitations; advancements include cell-sheet engineering and 3D technologies.
- Central necrosis in cell aggregates hinders efficacy in 3D culture systems.
Purpose of the Study:
- To introduce CellSaic, a novel cell transplantation platform.
- To highlight CellSaic's unique mechanism for preventing central necrosis in cell aggregates.
- To review CellSaic's characteristics, safety, and applications in mesenchymal stem cell transplantation.
Main Methods:
- Development of CellSaic: a xeno-free recombinant scaffold platform.
- Mosaic arrangement of cells and recombinant peptide (RCP) petaloid pieces.
- Evaluation of CellSaic's unique characteristics and safety examination results.
Main Results:
- CellSaic prevents central necrosis within cell aggregates, a key advantage over other 3D systems.
- MSC CellSaics demonstrated enhanced therapeutic effects compared to MSCs alone in various preclinical models.
- Successful applications noted in inflammatory bowel disease, cerebral infarction, joint cartilage regeneration, and islet transplantation.
Conclusions:
- CellSaic offers a significant advancement in 3D cell transplantation technology.
- The platform shows promise for improving MSC therapy efficacy across multiple conditions.
- CellSaic technology is anticipated to benefit both human and companion animal therapies under the "One Health" concept.
Related Concept Videos
Recombinant DNA
Viral Recombination
Peptide Bonds
Oxygen Delivering System III: Tracheostomy and T-piece
Tracheostomy
A tracheostomy is a surgically created opening (stoma) in the anterior part of the trachea. It is used to establish a patient airway, bypass an upper airway obstruction, simplify the removal of secretions, permit long-term...
Homologous Recombination
Overview of Transposition and Recombination

